Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research

被引:23
作者
Bertoni, F
Conconi, A
Cogliatti, SB
Schmitz, SFH
Ghielmini, M
Cerny, T
Fey, M
Pichert, G
Bertolini, F
Ponzoni, M
Baldini, L
Jones, C
Auer, R
Zucca, E
Cavalli, F
Cotter, FE
机构
[1] Oncol Inst So Switzerland, CH-6500 Bellinzona, Switzerland
[2] Barts & London, London, England
[3] Kantonsspital, Dept Pathol, St Gallen, Switzerland
[4] SAKK Stat Unit, Bern, Switzerland
[5] Kantonsspital, Dept Internal Med, St Gallen, Switzerland
[6] Univ Bern, Inselspital, CH-3010 Bern, Switzerland
[7] Univ Hosp, Dept Med, Zurich, Switzerland
[8] European Inst Oncol, Dept Med, Milan, Italy
[9] Ist Sci San Raffaele, I-20132 Milan, Italy
[10] State Univ Milan, Osped Maggiore, IRCCS, Milan, Italy
关键词
chromosome; 11q; immunoglobulin genes; somatic hypermutation; ataxia telangiectasia mutated gene; VH genes;
D O I
10.1046/j.1365-2141.2003.04763.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mantle cell lymphoma (MCL) shares immunophenotypic and karyotypic features with chronic lymphocytic leukaemia. The latter comprises two distinct entities with prognosis dependent upon immunoglobulin heavy chain (IgH) gene mutational status and the presence of 11q deletion. We evaluated the relevance of IgH gene mutational status, IgV gene family usage and presence of 11q deletion in a series of 42 histologically reviewed classical MCL cases to determine the prognostic impact. VH3 was the most common VH family, with VH3-21 being the most frequent individual VH gene. Approximately 30% of the cases had a IgH somatic mutation rate higher than 2%, but was only higher than 4% in <10% of cases. Half of the cases had deletion of chromosome 11q21-telomere (11q21->ter), with two minimal deleted regions, at 11q22.2 and 11q23.2. There was no association between 11q loss and IgH gene somatic mutation rate; the use of VH3-21 gene could be associated with a better prognosis.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 67 条
[1]  
AUER R, 2002, ANN ONCOL, V13, P102
[2]   Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia [J].
Auer, RL ;
Jones, C ;
Mullenbach, RA ;
Syndercombe-Court, D ;
Milligan, DW ;
Fegan, CD ;
Cotter, FE .
BLOOD, 2001, 97 (02) :509-515
[3]   Mantle-cell lymphoma [J].
Barista, Ibrahim ;
Romaguera, Jorge E. ;
Cabanillas, Fernando .
LANCET ONCOLOGY, 2001, 2 (03) :141-148
[4]  
Bentz M, 2000, GENE CHROMOSOME CANC, V27, P285, DOI 10.1002/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.3.CO
[5]  
2-D
[6]   Analysis of the human V-H gene repertoire - Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM(+) and CD5(-)/IgM(+) B cells [J].
Brezinschek, HP ;
Foster, SJ ;
Brezinschek, RI ;
Dorner, T ;
DomiatiSaad, R ;
Lipsky, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2488-2501
[7]   B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice [J].
Brunner, C ;
Marinkovic, D ;
Klein, J ;
Samardzic, T ;
Nitschke, L ;
Wirth, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1205-1211
[8]   Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium [J].
Buanne, P ;
Corrente, G ;
Micheli, L ;
Palena, A ;
Lavia, P ;
Spadafora, C ;
Lakshmana, MK ;
Rinaldi, A ;
Banfi, S ;
Quarto, M ;
Bulfone, A ;
Tirone, F .
GENOMICS, 2000, 68 (03) :253-263
[9]   ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances [J].
Camacho, E ;
Hernández, L ;
Hernández, S ;
Tort, F ;
Bellosillo, B ;
Beà, S ;
Bosch, F ;
Montserrat, E ;
Cardesa, A ;
Fernández, PL ;
Campo, E .
BLOOD, 2002, 99 (01) :238-244
[10]   Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations [J].
Camacho, FI ;
Algara, P ;
Rodríguez, A ;
Ruíz-Ballesteros, E ;
Mollejo, M ;
Martínez, N ;
Martínez-Climent, JA ;
González, M ;
Mateo, M ;
Caleo, A ;
Sánchez-Beato, M ;
Menárguez, J ;
García-Conde, J ;
Solé, F ;
Campo, E ;
Piris, MA .
BLOOD, 2003, 101 (10) :4042-4046